Literature DB >> 8989494

Effects of a modified-live virus vaccine against porcine reproductive and respiratory syndrome in boars.

J Christopher-Hennings1, E A Nelson, J K Nelson, D A Benfield.   

Abstract

OBJECTIVES: To determine whether vaccine virus is found in serum and semen of vaccinated boars, whether vaccination prevents subsequent shedding of wild-type virus after challenge exposure, and whether semen and blood variables are altered after vaccination or challenge exposure with wild-type virus, or both.
DESIGN: Throughout the 50-day postvaccination period, serum and semen from exposed boars were evaluated for the presence of porcine reproductive and respiratory syndrome virus (PRRSV). All boars were then challenge-exposed with PRRSV isolate VR-2332 and evaluated for an additional 27 days. Semen quality variables, serostatus, and blood variables were monitored. ANIMALS: 7 PRRSV-seronegative adult boars. PROCEDURE: Semen was collected 3 times weekly and evaluated by use of a nested reverse-transcriptase polymerase chain reaction for detection of PRRSV RNA. Serum was obtained weekly and evaluated by nested reverse-transcriptase polymerase chain reaction, virus isolation, and PRRSV ELISA. Semen quality variables were evaluated 3 times weekly, and CBC was performed weekly.
RESULTS: Vaccine virus was shed in the semen of all vaccinated boars, but shedding was of shorter duration in 4 of 5 vaccinated boars than that generally observed after exposure to wild-type virus. After challenge exposure, shedding of wild-type virus in semen was shortened or eliminated in 4 of 5 vaccinated boars. Percentage of forward movement and normal spermatozoal morphology and motility were significantly reduced in vaccinated boars after challenge exposure.
CONCLUSIONS: Vaccine virus was shed in semen of vaccinated boars, but vaccination generally reduced or eliminated shedding of wild-type PRRSV after challenge exposure. Semen quality appeared to be less than optimal, particularly after vaccination and subsequent challenge exposure with wild-type virus. CLINICAL RELEVANCE: Extra-label use of the PRRSV vaccine in boars remains controversial because some boars may still shed wild-type virus in semen after challenge exposure at postvaccination day 50. Semen quality also appeared to be altered after vaccination and subsequent challenge exposure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989494

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  15 in total

1.  Effect of the modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine on European and North American PRRSV shedding in semen from infected boars.

Authors:  Kiwon Han; Hwi Won Seo; Jeoung Hwa Shin; Yeonsu Oh; Ikjae Kang; Changhoon Park; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  Concurrent vaccination of boars with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) reduces seminal shedding of type 1 and type 2 PRRSV.

Authors:  Jiwoon Jeong; Changhoon Park; Ikjae Kang; Su-Jin Park; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-04       Impact factor: 1.310

Review 3.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.

Authors:  Wasin Charerntantanakul
Journal:  World J Virol       Date:  2012-02-12

4.  Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV.

Authors:  T Opriessnig; P G Halbur; K-J Yoon; R M Pogranichniy; K M Harmon; R Evans; K F Key; F J Pallares; P Thomas; X J Meng
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Porcine reproductive and respiratory syndrome virus replicates in testicular germ cells, alters spermatogenesis, and induces germ cell death by apoptosis.

Authors:  J H Sur; A R Doster; J S Christian; J A Galeota; R W Wills; J J Zimmerman; F A Osorio
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Comparison of commercial real-time reverse transcription-PCR assays for reliable, early, and rapid detection of heterologous strains of porcine reproductive and respiratory syndrome virus in experimentally infected or noninfected boars by use of different sample types.

Authors:  Priscilla F Gerber; Kevin O'Neill; Olajide Owolodun; Chong Wang; Karen Harmon; Jianqiang Zhang; Patrick G Halbur; Lei Zhou; Xiang-Jin Meng; Tanja Opriessnig
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

7.  Different biological characteristics of wild-type porcine reproductive and respiratory syndrome viruses and vaccine viruses and identification of the corresponding genetic determinants.

Authors:  Won-Il Kim; Jae-Jo Kim; Sang-Ho Cha; Kyoung-Jin Yoon
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

8.  Detection of U.S., Lelystad, and European-like porcine reproductive and respiratory syndrome viruses and relative quantitation in boar semen and serum samples by real-time PCR.

Authors:  A Wasilk; J D Callahan; J Christopher-Hennings; T A Gay; Y Fang; M Dammen; M E Reos; M Torremorell; D Polson; M Mellencamp; E Nelson; W M Nelson
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus.

Authors:  Hiep L X Vu; Byungjoon Kwon; Marcelo de Lima; Asit K Pattnaik; Fernando A Osorio
Journal:  Vaccine       Date:  2013-07-23       Impact factor: 3.641

10.  Comparative pathogenesis of type 1 (European genotype) and type 2 (North American genotype) porcine reproductive and respiratory syndrome virus in infected boar.

Authors:  Kiwon Han; Hwi Won Seo; Changhoon Park; Yeonsu Oh; Ikjae Kang; Chanhee Chae
Journal:  Virol J       Date:  2013-05-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.